
For your patients with newly diagnosed GBM
Optune Gio delivers the power of TTFields to attack GBM cells where they’re vulnerable1
A standard of care proven to provide long-term quality survival without adding systemic toxicity2-5,*
*Patient-reported data collected per EORTC QLQ-C30 at baseline and months 3, 6, 9, and 12. The 30-question survey covered 5 daily-functioning domains (Physical, Role, Social, Emotional, and Cognitive).3,6
GBM, glioblastoma; TTFields, Tumor Treating Fields.